MultiHance is contra-indicated in: patients with hypersensitivity to the active substance or to any of the excipients listed in Description; patients with a history of allergic or adverse reactions to other gadolinium chelates.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign Out
